We raise '25e-'27e EBITDA by 35-40% on the recent SEK 1bn order 2025 will be a strong year: sales +1...
Redeye provides a comment on this week’s news flow, with new data on BI-1206 in solid tumours and BI...
Redeye views Nanologica’s announcement of a SEK1.3m production-scale evaluation order for NLAB Saga ...
Karin Schreil, CEO, leaves her position at the end of 2025 She has implemented significant internal ...
Redeye briefly comments on yesterday’s news that the final reporting of the ELC-100 study will be po...
Redeye comments on Annexin's Q1 report and recent events in the company.
VBG Group redovisade en omsättning på 1 351 MSEK i Q1, en organisk minskning med 12,9 % jämfört med ...
Endomines published its updated strategy for 2025–2029, which largely builds on the previous one, wi...
Biovica sets precise sales targets after recording SEK 8.
Redeye comments on Monday’s milestone payment of SEK12m from Infiniteria.
Redeye is positive about Neola Medical’s agreement with Children’s Regional Hospital in New Jersey, ...
Redeye comments on Xbrane following its SEK240m directed share issue targeting both institutional an...
Redeye provides a brief on yesterday’s news from Nitro Games, which announced that publishing rights...
CapMan is a leader in the Nordic investment and asset management space with AuM of EUR 6.
Systemair redovisar ett stabilt fjärde kvartal 2024/25 med förbättrade marginaler och starkt kassafl...
Den välannonserade svackan i Q1 blev djupare än vi tänkt oss, men ruckar inte på bilden av ett välmå...
Redeye comments on GiG Software’s announcement of a directed share issue which strengthens the compa...
Redeye is only making minor changes to forecasts and valuation following the 2024/05 full year repor...
Redeye is positive about Optomed´s launch of its next-gen camera, Optomed Lumo.
